Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04493853
Title Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency (CAPItello-281)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements Yes
Sponsors AstraZeneca
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Capivasertib

Abiraterone

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | CAN | BEL | AUT

Additional content available in CKB BOOST